You are here: / IBO Blog

COVID-19 and RNA Prep

/in /by

Clinical diagnostic testing has been a major bottleneck throughout the global response to the COVID-19 pandemic, with severe shortages of testing reagents, lack or slow adaptation of existing infrastructure to administer tests, and very rapidly growing demand that is outpacing supply. The extraordinary demand for COVID-19 testing has strained the production capabilities of vendors in […]

Read more →

The Growing Potential of the Cell and Gene Therapy Market in 2020

/in /by

The development of cell and gene therapies has become an essential component of cancer and genetic disease research and treatment. Consequently, regulatory approvals for cell and gene therapy have begun to increase globally. As a result, cell and gene therapy research has expanded into other areas of medicine, such as treatments for autoimmune and dermatological diseases.

Read more →

A Steady Stream of New Funding for COVID-19 R&D

/in /by

This is the third of IBO’s review of R&D investments related to COVID-19 (see March 27 and April 17). The outbreak has triggered a wide range of responses spanning immediate and long-term solutions. For R&D, spending priorities range from areas  such as new diagnostic approaches and vaccine development to basic research in fields such as […]

Read more →

Ambiguity for the Analytical and Scientific Instrumentation Industry in Europe

/in /by

The analytical and scientific instrument market in Europe is a compelling situation. According to IBO’s publisher Strategic Directions International (SDi) and part of Science and Medicine Group, prior to the COVID-19 pandemic, the industry’s recent performance in the region has been modest with periods of both enthusiastic and tepid demand. Despite the region’s strong presence […]

Read more →
Access IBO on Knowledge Center
Science and Medicine Group. © 2019 - Privacy Policy - All rights reserved.